Predicting the outcome of psoriasis treatment

Anthony Ormerod* (Corresponding Author)

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review


Biomarker research embraces many disciplines, using advances in high-throughput molecular biology and computers to measure molecules directly involved in the disease process. Importantly, translational medicine requires close collaboration between clinical researchers, to have accurate phenotypes and to be able to adjust for established prognostic factors. In practice, the predictors of biomarkers will need to be assessed alongside clinical phenotypic and demographic factors.
Original languageEnglish
Pages (from-to)458-459
Number of pages2
JournalBritish Journal of Dermatology
Issue number4
Early online date22 Jul 2022
Publication statusPublished - 1 Oct 2022

Bibliographical note

I thank David Burden and Andrew Pink for valuable comments and suggestions.


Dive into the research topics of 'Predicting the outcome of psoriasis treatment'. Together they form a unique fingerprint.

Cite this